{"id":41471,"date":"2023-11-20T01:31:50","date_gmt":"2023-11-20T07:31:50","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/s0819-data\/"},"modified":"2023-11-20T01:31:50","modified_gmt":"2023-11-20T07:31:50","slug":"s0819-data","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/s0819-data\/","title":{"rendered":"S0819-DATA"},"template":"","class_list":["post-41471","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Data Citation","tcia_citation_text":"<p><span><span>Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T. J., Bazhenova, L., Masters, G., Oettel, K., Guaglianone, P., Reynolds, C., Karnad, A., Arnold, S. M., Varella-Garcia, M., Moon, J., Mack, P. C., Blanke, C. D., Hirsch, F. R., Kelly, K., &amp; Gandara, D. R. (2023). <strong>A Randomized Phase III Study Comparing Carboplatin\/Paclitaxel or Carboplatin\/Paclitaxel\/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer (S0819)<\/strong> (Version 2) [Data set]. The Cancer Imaging Archive<\/span>. <a href=\"https:\/\/doi.org\/10.7937\/DT39-JS04\">https:\/\/doi.org\/10.7937\/DT39-JS04<\/a><\/span><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.7937\/DT39-JS04","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/41471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=41471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}